2. UDI System
Appropriate level of traceability of medical
devices within supply chain
BASIC UDI-DI identifies device model
UDI-DI identifies model and serves as access
key to UDI database
UDI-PI identifies the unit of device production
Internationally recognized nomenclature
The obligation for UDI assignment applies as
of 26 May 2020 for medical devices
EUDAMED’s launch will be done together for
medical and in-vitro devices in May 2022.
PAGE 2
https://www.fda.gov/medical-devices/unique-device-identification-system-udi-system/udi-basics
4. EUDAMED
The new EUDAMED database will include:
Registration of devices
Unique Device Identifiers
Registration of economic operators (except for
distributors)
Notified bodies, Certificates
Clinical investigations
Vigilance, Post-market surveillance
Market surveillance (inspections, non-
compliance, health protection measures)
PAGE 4
Article 29, 30, 31
Part A of Annex VI
https://ec.europa.eu/docsroom/documents/33862/attachments/1/translations/en/renditions/native
Functional specifications defined by EC and
Medical Device Coordination Group (MDCG)
Information accessible to general public
information on UDIs facilitates traceability
Information on clinical investigations
Reporting serious incidents
Field Safety Corrective Actions
EUDAMED will serve EU/EEA authorities to
cooperate and exchange information
6. PAGE 6
REGISTRATION OF DEVICES
Before placing a device on the
market, manufacturers shall assign
Basic UDI-DI
Whoever places procedure packs
on the market shall assign Basic
UDI-DI
Enter/verify information in
Eudamed
7. Registration of
economic operators
Manufacturers, Authorized Representatives and Importers must register in EUDAMED
Competent Authority obtains and issues a Single Registration Number (SRN)
The manufacturer shall use SRN when applying to Notified Body for Conformity Assessment
Any changes shall be reported within 1 week
Semi-annual confirmation of correctness of data
Competent authority verifies data from economic subjects
Information submitted to EUDAMED shall be available to the public
Competent authorities can use information from EUDAMED to collect fees
PAGE 7
Article 31
Part A of Annex VI
8. Summary of Safety and Clinical Performance
Implantable and Class III devices
Summary must be clear to intended user
Draft shall be submitted to Notified body
as part of Conformity Assessment
Available via EUDAMED after validation
PAGE 8
Article 32
Part A of Annex VI
CONTENT
Identification, Basic UDI-DI, SRN
Intended purpose, indications
Contraindications
Target populations
Description of the device
Diagnostic and therapeutic alternatives
Reference to any harmonized standards
Summary of clinical evaluation
Suggested profile and training for users
Residual risks, undesirable effects, warnings, precautions